Lawsuit Overview
May 13, 2022 - An investor in shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Axsome Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between December 30, 2019, and April 22, 2022. New York based Axsome Th...
You must register (for free) or login to view the entire case.